Gil Schwartzberg serves as Executive at LIXTE BIOTECHNOLOGY HOLDINGS, INC., where they oversee executive responsibilities. Since joining the company, Gil Schwartzberg has executed 8 insider transactions totaling $1.1M, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 3, 2021 involved gifting 7,000 shares valued at $0.
Gil Schwartzberg currently holds 215,775 shares of LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gil Schwartzberg has been a net buyer of LIXT stock. They have purchased $1.1M and sold $0 worth of shares.
Gil Schwartzberg's most recent insider trade was on Sep 3, 2021, when they sold 7,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 3, 2021 | LIXT | $0 | Gift | 15,000 | $N/A | Discretionary |
| Nov 30, 2020 | LIXT | $500.0K | Purchase | 105,264 | $4.75 | Discretionary |
| Dec 7, 2018 | LIXT.OB | $0 | Gift | 600,000 | $N/A | Discretionary |
| Dec 7, 2018 | LIXT.OB | $520.0K | Purchase | 1,040,000 | $0.50 | Discretionary |
| Dec 7, 2018 | LIXT.OB | $0 | Other | 150,000 | $N/A | Discretionary |
| Jan 11, 2017 | LIXT | $60.3K | Purchase | 1,005,556 | $0.06 | Discretionary |